Basil T. Darras, MD, is the Joseph J. Volpe Professor of Neurology at Harvard Medical School. At Boston Children’s Hospital, Dr. Darras is Associate Neurologist-in-Chief and Chief of the Division of Clinical Neurology. He is Director of Boston Children’s Neuromuscular Program, which includes one of the oldest and most active Muscular Dystrophy Association clinics in the country. Dr. Darras is a pediatric neurologist with advanced training and certification in human genetics and neuromuscular medicine. His primary research focus is in the field of pediatric neuromuscular disorders. His specific research interests and major publications have focused on the molecular genetics, diagnostics, and therapeutics of Duchenne muscular dystrophy, Becker muscular dystrophy, spinal muscular atrophy (SMA), and other myopathies, and on defining the indications for new diagnostic methodologies in the evaluation of children with pediatric neuromuscular diseases. His clinical focus is the care of children with neuromuscular conditions originating from inherited or acquired conditions of the motor unit. He is Principal Investigator for the Boston Children’s site of NIH’s NeuroNEXT clinical research network, for the SMA Foundation’s Spinal Muscular Atrophy PNCR Network, and for trials testing novel treatments for SMA, including the clinical trials for Spinraza® and Zolgensma®, recently approved by the FDA as the first treatments for SMA. He is frequently invited to lecture at national and international meetings on topics related to his expertise in neuromuscular disorders and genetics. He has published over 190 original reports in peer-reviewed journals and over 80 chapters, reviews and editorials, and is Editor-in-Chief for the second edition of Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician’s Approach, published by Elsevier in 2015.